Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Pharming Group N.V. (“Pharming” or the “Company”) (NASDAQ: PHAR) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON PHARMING GROUP N.V. (PHAR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On July 30, 2026, the Company reported second quarter earnings, including revenue of $90.2 million, reflecting a 3.2% year over year decline. Further, the Company reported a 10% revenue decline for RUCONEST. The Company stated, among other things, that “the year-over-year decline reflected... temporary inventory normalization." The Company also cut its full year revenue guidance approximately $30 million at the midpoint to $375 to $395 million and stated “[a]t the midpoint of our guidance range, RUCONEST U.S. revenue is expected to decline approximately 3% for the full year."

On this news, Pharming Group shares fell $1.26 or 10.5% per share to close at $10.75, on July 30, 2026, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Pharming Group N.V. securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com.
Email us at: [e-mail]
Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.